Tyra Biosciences (TYRA) Non-cash Items (2021 - 2026)

Tyra Biosciences has reported Non-cash Items for 6 years, with the latest figure at $6.0 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items rose 13.51% year-over-year to $6.0 million; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (up 13.51% YoY), and the FY2025 full-year result was $6.3 million, up 24.94% from the prior year.
• Non-cash Items for Q1 2026 stood at $6.0 million, down from $186.7 million in the prior quarter.
• The five-year high for Non-cash Items was $186.7 million in Q4 2025, with the low at $891348.0 in Q1 2022.
• Historically, Non-cash Items has averaged $39.8 million across 5 years, with a median of $33.8 million in 2024.
• Annual changes were most pronounced in 2023 — Non-cash Items jumped 6171.06% — and 2025, when it slumped 90.74%.
• Tyra Biosciences' Non-cash Items stood at $13.5 million in 2022, then jumped by 199.58% to $40.4 million in 2023, then retreated by 16.38% to $33.8 million in 2024, then surged by 452.31% to $186.7 million in 2025, then slumped by 96.8% to $6.0 million in 2026.
• The last three Non-cash Items figures came in at $6.0 million (Q1 2026), $186.7 million (Q4 2025), and $46.0 million (Q3 2025), per Business Quant data.